Regarding the CSRD domain, previous studies suggested that patients harboring mutations in this domain had a higher risk of developing optic pathway glioma OPG than patients with mutations in other regions [4], however, further studies are still needed to confirm associations between NF1 genotype and OPG phenotype. The gene discussed is NF1; the disease is optic pathway glioma.